22NW LP’s Cross Country Healthcare CCRN Stock Holding History

22NW LP’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-375,758	Closed	-$2.75M	–	44
2018 Q4	$2.75M	Buy	375,758 +69,833	+23%	+$585K	1.72%	24
2018 Q3	$2.67M	Buy	+305,925	New	+$3.12M	1.43%	27

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

BSP

Benefit Street Partners New York $86.4M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

22NW LP's CCRN Position: Q1 2019 in Review

22NW LP sold out of Cross Country Healthcare (CCRN) in Q1 2019, closing a stake of 375,758 shares — an estimated $2.75M sold.

22NW LP first reported a position in CCRN in Q3 2018 and held it in 2 quarters. The position peaked at $2.75M in Q4 2018. 131 funds tracked by Wall St. Rank hold CCRN as of Q1 2019.

22NW LP reported no remaining Cross Country Healthcare position as of Q1 2019 after selling out during the quarter.
22NW LP sold 375,758 Cross Country Healthcare shares in Q1 2019, an estimated $2.75M.
22NW LP first reported a position in Cross Country Healthcare in Q3 2018 and held it in 2 quarters.
22NW LP's Cross Country Healthcare position peaked at $2.75M in Q4 2018.
131 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2019.

Based on 22NW LP's 13F filing for Q1 2019, filed 15 May 2019.